Renata Limited
Pharmaceutical company in Bangladesh
From Wikipedia, the free encyclopedia
Renata PLC (formerly Pfizer Laboratories (Bangladesh) Limited), also known as Renata Limited, is one of the top ten pharmaceutical manufacturers in Bangladesh in terms of revenue.[1] Renata is engaged in the manufacture and marketing of human pharmaceutical and animal health products.[2] The company also manufactures animal therapeutics and nutrition products. As of 2024, Renata employs about 11,000 people in its head office in Mirpur, Dhaka[3] and its 14 production facilities in Mirpur, Dhaka, Rajendrapur, Gazipur and Bhaluka, Mymensingh.[4]
 | |
| Company type | Limited Company |
|---|---|
| DSE: RENATA | |
| Industry | Pharmaceutical |
| Founded | 1993 |
| Headquarters | , Bangladesh |
Area served | South Asia, South East Asia, Africa, Europe and Latin America |
Key people | Syed S Kaiser Kabir (CEO) |
| Products | Maxpro, Rolac, Fenadin, Rolip, Furoclav and more |
Number of employees | 3485 |
| Website | renata-ltd |
Financial data
Renata is a publicly traded company on the Dhaka Stock Exchange (ticker: RENATA).[5]
Production facilities
Recently, Renata Limited has received the UK MHRA approval for its Potent Product Facility.[6] This facility is exporting prednisolone to the UK.[7]
The company also operates four other manufacturing units – the original Pfizer facility for general products, a UNICEF-approved SFF (Sachet Filling Facility).[8]
Partnerships
Controversy
Renata was fined on 21 January 2016 by the Department of Environment for damaging the environment. The company has also illegally occupied land owned by the forest department.[10] Syed S. Kaiser Kabir, the CEO, of the company had illegally grabbed government land to build a house near Dhaka-Mymensingh highway.[11]